Retatrutide is a triple-receptor agonist targeting GLP-1, GIP, and glucagon pathways simultaneously, producing an average of 24.2% body weight reduction in Phase 2 clinical trials at the 12mg dose
Promotes a Healthy Gut Microbiome A clinically formulated probiotic blend that helps maintain gut balance, support digestion, and promote healthy immune function
The Evaluate Renal Function with Semaglutide Once Weekly (FLOW) trial, published earlier this year, is the first to specifically investigate kidney outcomes with GLP-1 receptor agonists
Gabys case series (2002) demonstrated success treating fatigue, asthma, fibromyalgia, migraines, allergies, depression, and chronic hives with the Myers formula